 | Up a level |
2020
Baehr, O., Tabatabai, G., Fietkau, R., Goldbrunner, R. and Glas, M. (2020). The use of TTFields in Germany in routine clinical care of newly diagnosed GBM patients (TIGER: TTFields in Germany in routine clinical care). Strahlenther. Onkol., 196 (SUPPL 1). S. S63 - 2. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-099X
2018
Baehr, O., Tabatabai, G., Fietkau, R., Goldbrunner, R. and Glas, M. (2018). THE USE OF TTFIELDS FOR NEWLY DIAGNOSED GBM PATIENTS IN GERMANY IN ROUTINE CLINICAL CARE (TIGER: TTFIELDS IN GERMANY IN ROUTINE CLINICAL CARE). Neuro-Oncology, 20. S. 252 - 253. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
2016
Hecht, M., Hahn, D., Beutner, D., Reichert, D., Goehler, T., Wurm, R., Welslau, M., Renziehausen, L., Balermpas, P., Bergmann, T., Assmann, M., Belka, C., Orlowski, K., Finzsch, M., Illerhaus, G. and Fietkau, R. (2016). Cetuximab in combination with platinum-based chemotherapy or radiotherapy in recurent and/or metastatic SCCHN in a non-selected patient cohort (interim analysis of the phase IV SOCCER trial). Ann. Oncol., 27. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041
Hecht, My, Hahn, D., Beutner, D., Reichert, D., Goehler, T., Wurm, R., Welslau, M., Renziehausen, L., Balermpas, P., Bergmann, T., Assmann, M., Belka, C., Orlowski, K., Finzsch, M., Illerhaus, G. and Fietkau, R. (2016). Cetuximab in combination with platinum-based chemotherapy or radiotherapy in recurent and/or metastatic SCCHN in a non-selected patient cohort (interim analysis of the phase IV SOCCER trial). Oncol. Res. Treat., 39. S. 171 - 172. BASEL: KARGER. ISSN 2296-5262